… immunotherapy strategy, shows a promising prospect in future. Here, we conduct a
comprehensive review concerning the advance of vaccine for colorectal cancer in … …

… Colorectal cancer is the second common cause of cancer death. Immunotherapy has became
a new therapy apart from traditional therapy such as surgery,etc. There are controversial …

… :Phase E randomized study of pembrolizumab versus … with metastatic colorectal cancer:a
phase Ib/Ⅱ clinical trial and gut … Phase Ia and Ib studies of the novel carcinoembryonic antigen (…

… and HER2-related immunotherapy alone or in combination … -2/neu in advanced colorectal
cancer limits the usefulness of … A pilot trial of vaccination with carcinoembryonic antigenand …

… Immunotherapy for metastatic colorectal cancer: present … advanced colorectal cancer and
suspected minimal residual … avipox vaccine containing both carcinoembryonic antigen (CEA) …

… metastatic colorectal cancer (mCRC) featuring DNA mismatch repair deficiency/high microsatellite
instability has significant clinical … the research progress on combined immunotherapy …

… immunotherapy, their applications in colorectal cancer, and the advantages and disadvantages
of different methods of immunotherapy. … microenvironment and immunotherapy, and the …

… repair⁃proficient advanced colorectal cancer treated by immunotherapy combined with …
,NLR=中性粒细胞计数/淋巴细胞计 数,CIPI=癌胚抗原(carcinoembryonic antigen,CEA) 水平×中性粒…

… through enhanced retention of human colorectal carcinoma cells … adjuvant for immunotherapy,
specifically in cancer vaccines . We … Interleukin-6 increases carcinoembryonic antigen and …

… Current status and prospect of CAR⁃T cell immunotherapy for colorectal cancer … T cells
targeting carcinoembryonic antigen can mediate re⁃ gression of metastatic colorectal cancer but …